Burkhard Blank
Chief Tech/Sci/R&D Officer chez MANNKIND CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
Burkhard Blank is currently the Chief Medical Officer and EVP-Research & Development at MannKind Corp.
Prior to this, he held the position of Chief Medical Officer and Head-Research & Development at Acorda Therapeutics, Inc. from 2016 to 2021.
He also served as the Chief Executive Officer at Laurantis Pharma Oy in 2013-2014.
Blank was the Chief Medical Officer & Executive Vice President at Altus Pharmaceuticals, Inc. from 2006 to 2009 and the SVP-Medicine & Drug Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. from 2001 to 2006.
He has also worked at RIEMSER Pharma GmbH, Acorda Therapeutics, Inc., Mersana Therapeutics, Inc., Pharnext SA, and Herantis Pharma Oyj.
Blank holds a doctorate degree from Philipps University of Marburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MANNKIND CORPORATION
0,14% | 04/02/2024 | 367 905 ( 0,14% ) | 2 M $ | 31/03/2024 |
Postes actifs de Burkhard Blank
| Sociétés | Poste | Début |
|---|---|---|
| MANNKIND CORPORATION | Chief Tech/Sci/R&D Officer | 24/05/2023 |
Anciens postes connus de Burkhard Blank
| Sociétés | Poste | Fin |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Chief Executive Officer | 01/05/2014 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 27/03/2009 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01/06/2006 |
| ACORDA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Burkhard Blank
| Philipps University of Marburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| MERSANA THERAPEUTICS, INC. | Health Technology |
| PHARNEXT SCA | Health Technology |
| HERANTIS PHARMA OYJ | Health Technology |
| Entreprise privées | 4 |
|---|---|
RIEMSER Pharma GmbH
 RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Health Technology |
